Discussion about this post

User's avatar
Tadeusz's avatar

Thanks for this important and informative voice, Amanda.

I didn’t even register before the statistic saying that 39% people listed psychedelic experience in their top five most difficult experiences in their lifetime. We just like to repeat another number speaking about one of the most meaningful experiences in people’s lives, but it seems only fair to speak about both sides.

But I also resonate with Pollan’s view that we need to be wary of the inflation of adverse effects. It’s the context that changes everything. In the medical context, no effective medicine is without risk and the benefits of a medicinal product always need to be weighed up against its risks. Also, when we speak about risks related to psychedelic therapies, we should be comparing them with risks of other licenced medicines for similar indications. And finally, with often catastrophic risks that several mental health conditions expose people to.

But I couldn’t agree more with you about a fallacy of viewing the psychedelic experience as a shortcut to enlightenment without doing the necessary inner work and that integration should be at the very forefront of our efforts. And your remark: “Integration, from my perspective, means choosing to engage less with psychedelics and instead living more presently in the realities of our non-altered state” is spot on!

I believe that creating sustainable integration models is currently one of the most urgent issues. I like Thomas Insel approach to mental health. He advocates broad care involving integrated teams of psychiatrists, psychologists, primary-care nurses and social workers. Because just getting a person through a mental-health crisis doesn’t necessarily help their long-term prospects. They need support to stay on their medication or work on sustaining the beneficial outcomes from therapy, to look after their general health and to get their personal lives back on track.

Related to this, in the psychedelic circles there’s a lot of talk about integration meaning processing one’s trip. But of course, integration is not just an individual matter. Healing is not. For integration to be truly beneficial, on one level it’s realizing it’s not just me and you. We are living in a culture that is suffused in anxiety, epidemic of loneliness. We need each other, we need to be heard and seen. Healing is not an individual matter. This is why it’s a dead-end to “biologise” all mental illness, which can ignore the cultural dynamics that are producing the problem in the first place. Then, one level up, psychedelics should be integrated into a social vision of equality and justice.

There needs to be more conducive environments for healing rather than damaging us further. And more planetary awareness. I mean, just think about this: Clinical trials of psychedelic therapies are being conducted in the western world and culture, in rich countries, yet 84% of people affected by mental illness live in low and middle-income countries. Will these western-style psychedelic therapeutic modalities be even appropriate or effective in, say, India who is taking over this year as the most populated nation? And when will they reach them, 10 years later as this is often the case with innovative treatments? Shame on us and our colonial mindsets.

Another important issue you raise is medicalization/magic pill and how all this is putting pressure on science, often funded by big pharma companies, to produce results focusing on the positive. This is pushing us towards a drive-thru prescription mentality. And it is touching on hugely systemic issues such as patents and capitalism. What is more specific to psychedelics here is the international drug-scheduling system that needs to be reformed to ensure that psychedelics with strong medicinal potential are more accessible to scientists and patients before they are approved by regulators like EMA and FDA. Scheduling created mountains of stigma and resulted in decades of no funding, especially public one. The lack of public funding has been further undermining the ability of academics to pursue psychedelics research. Disadvantaged scientists, who are not affiliated with the industry, are often less resourced than their industry counterparts. Consequently, industry and private donors typically fund psychedelic trials. This situation artificially stifles competition, therapeutic innovation, and access by granting monopolies to companies that develop proprietary therapeutics. As such, the regulatory constraints and patent incentives create a pharmaceutical landscape that privileges high-cost synthetic variants over existing substances. For these reasons, relying predominantly on industry-supported research to achieve the regulatory approval is not an equitable solution to rescheduling psychedelics with medicinal properties. And yet, currently approval of scheduled medicines and rescheduling are effectively synonymous.

Regarding your thoughts about research not being innocent to data distortion and misleading outcomes, it’s helpful to have a wider context. It is estimated that about 20% of clinical trials are false. Very few papers are retracted. Check this must read from the 2021 BMJ publication: “Time to assume that health research is fraudulent until proven otherwise?” https://bit.ly/428VX91

Lastly, but this is so important, voices like yours help people who had challenging/unresolved experiences to validate their experiences and often their suffering. It’s so important to be actively creating this open culture which encourages sharing things that are not positive and thank you for doing so.

Expand full comment
Gv Freeman's avatar

This may be an oversimplified approach but 9 our of 10 times, a "bad trip" teaches people they a) are not qualified to be their own sitter b) took too much c) are in an unsafe place with unsafe people. I totally agree that individuals can be re-traumatized...but it's not the psychedelics fault. A rock in "bad" hands killed Abel. A rock in "good" hands killed Goliath. What you call the psychedelic shadow, I think points more closely at the shadow of the user.

Expand full comment
1 more comment...

No posts